Clinical Trial Update: Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating enalapril to treat heart damage in childhood cancer patients who received anthracycline chemotherapy has completed. No trial results ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure

Drugs mentioned

• Enalapril (enalapril)

Snippet

Sponsor: Children's Oncology Group | Conditions: Cardiac Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED